CXCL8 and cancer: Since in patients with cancer, IL-8 is mainly produced by tumour cells, its serum concentration has been shown to be correlated with the tumour burden, and IL-8 is an effective pharmacodynamic biomarker to detect an early response to immunotherapy [26].